Skip to main content
SpringerLink
Log in

Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Epidemiological, clinical and animal studies indicate non-steroidal anti-inflammatory drugs (NSAIDs) to be chemopreventive for colorectal cancer. The best established target for NSAIDs are the two isoforms of cyclooxygenase (COX), a key enzyme in the biosynthesis of prostaglandins. Recent investigations using human colorectal tumor cell lines have focused on the cellular and molecular mechanisms potentially underlying the chemopreventive effect of NSAIDs. These studies have used ‘traditional’ NSAIDs and their metabolites which either do not inhibit COX, are non-selective for the COX isoforms or selectively inhibit COX-1 over COX-2, and recently developed NSAIDs that are highly selective for COX-2. In vitro, apoptosis is the dominant anti-proliferative effect of each of these classes of NSAID and sensitivity to NSAID-induced apoptosis increases with the malignant potential of the tumor cells. Limited in vivo evidence backs up these findings. Cell cycle arrest also contributes to the in vitro growth inhibitory effect of traditional NSAIDs. The induction of apoptosis by NSAIDs may result from the inhibition of the COX isoforms but other as yet undefined paths to NSAID-induced apoptosis clearly exist. A member of each class of NSAID is under trial as a chemopreventive agent for colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. In: DuBois RN and Giardiello FM, eds. NSAIDs, Eicosanoids, and the Gastroenteric Tract. Gastroenterology Clinics of North America, Vol. 25. Philadelphia: Saunders, 1996: 333–348.

    Google Scholar 

  2. Giariello FM. NSAID-induced polyp regression in familial adenomatous polyposis patients. In: DuBois RN and Giardiello FM, eds. NSAIDs, Eicosanoids, and the Gastroenteric Tract. Gastroenterology Clinics of North America, Vol. 25. Philadelphia: Saunders, 1996: 349–361.

    Google Scholar 

  3. Pugh S, Thomas GAO. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut 1994; 35: 675–678.

    Google Scholar 

  4. Qiao L, Kozoni V, Tsioulias GJ, et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim et Biophys Acta 1995; 1258: 215–223.

    Google Scholar 

  5. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183–1188.

    Google Scholar 

  6. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and-2 in human colorectal cancer. Cancer Res 1995; 55: 3785–3789.

    Google Scholar 

  7. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res 1995; 55, 2556–2559.

    Google Scholar 

  8. Kutchera W, Jones DA, Matsunami N, et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 1996; 93: 4816–4820.

    Google Scholar 

  9. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493–501.

    Google Scholar 

  10. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336–3340.

    Google Scholar 

  11. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 705–716.

    Google Scholar 

  12. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–809.

    Google Scholar 

  13. Piazza GA, Alberts DS, Hixson LJ, et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997; 57: 2909–2915.

    Google Scholar 

  14. Thompson HJ, Jiang C, Lu J, et al. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res 1997; 57: 267–271.

    Google Scholar 

  15. Wechter WJ, Kantoci D, Murray ED, et al. R-Flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC Min/+ mouse model: Implications for prophylaxis and treatment of colon cancer. Cancer Res 1997; 57: 4316–4324.

    Google Scholar 

  16. Elder DJE, Paraskeva C. COX-2 inhibitors for colorectal cancer. Nature Med 1998; 4: 392–393.

    Google Scholar 

  17. van Stolk R, Budd GT, Kresty R, et al. Effect of sulindac sulfone on proliferation, apoptosis and polyps in a clinical trial in familial adenomatous polyposis (FAP) with rectal polyps. Gastroenterology 1998; 114(4): G2881.

    Google Scholar 

  18. Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55: 1811–1816.

    Google Scholar 

  19. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 1996; 93: 7950–7954.

    Google Scholar 

  20. Shiff SJ, Qiao L, Tsai L, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinma cells. J Clin Invest 1995; 96: 491–503.

    Google Scholar 

  21. Piazza GA, Rahm ALK, Krutzsch M, et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995; 55: 3110–3116.

    Google Scholar 

  22. Piazza GA, Rahm AK, Finn TS, et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 1997; 57: 2452–2459.

    Google Scholar 

  23. Hanif R, Pittas A, Feng Y, et al. Effects of nonsteroidal antiinflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin—independent pathway. Biochem Pharmacol 1996; 52: 237–245.

    Google Scholar 

  24. Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 1996; 222: 179–188.

    Google Scholar 

  25. Qiao L, Hanif R, Sphicas E, Shiff SJ, Rigas B. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 1998; 55: 53–64.

    Google Scholar 

  26. Elder DJE, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 1996; 56: 2273–2276.

    Google Scholar 

  27. Pasricha PJ, Bedi A, O'Connor K, et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 1995; 109: 994–998.

    Google Scholar 

  28. Keller JJ, Offerhaus GJA, Goodman SN, et al. Change in apoptosis in patients treated with sulindac. Gastroenterology 1998; 114(4): G2550.

    Google Scholar 

  29. Goldberg Y, Nassif II, Pittas A, et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996; 12: 893–901.

    Google Scholar 

  30. Ricchi P, Pignata S, Di Popolo A, et al. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer 1997; 73: 880–884.

    Google Scholar 

  31. Wallace, JL Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997; 112: 1000–1016.

    Google Scholar 

  32. Takahashi M, Fukutake M, Yokota S, Ishida K, Wakabayashi K, Sugimura T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. J Cancer Res Clin Oncol 1996; 122, 219–222.

    Google Scholar 

  33. Reddy BS, Rao CV, Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996; 56: 4566–4569.

    Google Scholar 

  34. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemoprevention activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409–412.

    Google Scholar 

  35. Hara A, Yoshimi N, Niwa M, Ino N, Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Japanese Jnl Cancer Res 1997; 88: 600–604.

    Google Scholar 

  36. Elder DJE, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal antiinflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 1997; 3: 1679–1683.

    Google Scholar 

  37. Sheng GG, Shao J, Sheng H, et al. A selective cyclooxygenase-2 inhibitor (SC-58125) suppresses the growth of H-ras Transformed rat intestinal epithelial cells. Gastroenterology 1997; 113: 1883–1891.

    Google Scholar 

  38. Arber N, Han EK, Sganbato A, et al. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology 1997; 113: 1892–1990.

    Google Scholar 

  39. Bouck N. p53 and angiogenesis. Biochim Biophys Acta 1995; 1287: 63–66.

    Google Scholar 

  40. Harris N, Kaznov D, Pick M, et al. c-K-ras transformed rat enterocytes (R1) are more sensitive than normal enterocytes (IEC18) to growth inhibition and apoptosis-induced by sulindac sulfone and nimesulid. Gastroenterology 1998; 114(4): G2496.

    Google Scholar 

  41. Singh J, Kulkarni N, Kelloff G, Reddy BS. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis 1994; 15: 1317–1323.

    Google Scholar 

  42. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998; 95: 681–686.

    Google Scholar 

  43. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362–366.

    Google Scholar 

  44. Elder DJE, Halton DE, Paraskeva C. Cellular and molecular effects of a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug on colorectal adenoma and carcinoma cell lines. Gastroenterology 1998; 114(4): G2416.

    Google Scholar 

  45. Chulada PC, Doyle C, Gaul B, et al. Cyclooxygenase-1 and-2 deficiency decrease spontaneous intestinal adenomas in the Min mouse. Proc Am Assoc Cancer Res 1998; 39: 195.

    Google Scholar 

  46. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 97: 2254–2259.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK

    D. J. E. Elder & C. Paraskeva

Authors
  1. D. J. E. Elder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Paraskeva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elder, D.J.E., Paraskeva, C. Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs. Apoptosis 4, 365–372 (1999). https://doi.org/10.1023/A:1009696505108

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009696505108

Search

Navigation